Omnicare at Almost $10 Billion Still Worth It for CVS: Real M&A

For Omnicare Inc.’s potential suitors, even a $9.8 billion price tag could more than pay for itself.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.